Tony Nominee Xanthe Elbrick to Lead Cast of Mêlisa Annis' Charlie's Waiting

Off-Broadway News   Tony Nominee Xanthe Elbrick to Lead Cast of Mêlisa Annis' Charlie's Waiting
 
The world premiere from Parity Productions will begin performances in March 2019 at Theaterlab.
Xanthe Elbrick
Xanthe Elbrick Joseph Marzullo/WENN

Tony nominee Xanthe Elbrick (Coram Boy) will lead the cast of Parity Productions' world premiere of Charlie's Waiting by Mêlisa Annis. The new play, the first production to come from Parity's annual commissioning pipeline, follows two women the night before their wedding.

Charlie's Waiting will also star Amy Scanlon (One Flew Over the Cuckoo’s Nest, It Runs in the Family). Performances will begin March 29, 2019, and continue through April 14 at Theaterlab (357 W 36th St, New York).

“What you’ll find about Melisa’s work is that she can make you laugh and turn the table on you in a way that you weren’t expecting in her extraordinary manner of playwriting,” says Parity Founder and Artistic Director Ludovica Villar-Hauser, who is also directing.

Parity Productions is a producer of new work that ensures at least 50 percent of the creative positions are women and/or trans and gender nonconforming (TCNG) artists.

“Parity has afforded me an incredible home for further development and production of Charlie’s Waiting. I couldn’t be more pleased about the process and working with a company that is so steadfast in its mission and commitment to a diverse array of artists,” says playwright Annis.

In Charlie's Waiting, a very pregnant Louise is busy with all the planning while her fiancée Kelly busies herself feeding the goats. Everything is going to plan, that is until Louise is forced to confront questions of trust and intimacy, and she discovers how quickly plans can get derailed. For tickets, click here.

Click Here to Shop for Theatre
Merchandise in the Playbill Store
 
Latest News
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!